Click on the presentation links below to watch the individual sessions by Javier Cortes, Nadia Harbeck and George W Sledge Jr.

The webcast includes presentations, case studies and panel discussion.

To watch the full webcast and answer pre- and post-assessment questions, please click to register and watch now.

This program is suitable for global oncologists and other healthcare professionals involved in the diagnosis, treatment, and follow-up of patients with breast cancer.

Chapter 1 – Welcome & Introduction
Chapter 2 – Guidelines and Evidence
Chapter 3 – Patient Selection and Sequencing
Chapter 4 – Monitoring and Managing Treatment Related Toxicities
Chapter 5 – Panel Discussion

Click the links in the program below to watch the free webcast sessions.

Duration Session Speaker
5 mins
Javier Cortes
10 mins
Javier Cortes
15 mins
Nadia Harbeck
15 mins
George W Sledge Jr.
12 mins
3 mins
Summary and close
Javier Cortes
Evaluation and accreditation

In support of improving patient care, the webcast activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME), Imedex, and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this on-demand activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to claim your credits

To claim your credits for participating in the accredited activities, you will need to watch the full webcast, then fill out this short evaluation form and tick the appropriate box for certification.

Disclosure of relevant financial relationships

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

NACCME requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COIs are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Planning committee

In addition to the speaker faculty, NACCME and Springer Healthcare IME planners and staff include Chris Bolwell, James Hutton and Rebecca Hills.

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service. James Hutton and Rebecca Hills have no financial relationships to disclose.


This activity is supported by an educational grant from Lilly.